Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease
- PMID: 16385259
Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease
Abstract
Objective: Central adiposity, a component of insulin resistance syndrome, is a risk factor for nonalcoholic fatty liver disease (NAFLD) in adults. To determine whether a similar relationship occurs in children, hepatic fat content and adipose tissue distribution were assessed in obese children at risk for NAFLD.
Methods: We reviewed the charts of obese children undergoing evaluation for NAFLD because of hepatomegaly or elevated serum alanine aminotransferase (ALT) without obvious etiology. Hepatic fat fraction and adipose tissue distribution were obtained by rapid magnetic resonance imaging (MRI) techniques. Hepatic fat content was determined by a modification of the Dixon method that involves fast gradient echo. Body fat distribution was assessed by using heavily T1-weighted fast gradient echo technique on a single slice at the level of the umbilicus, and regions of interest were demarcated based upon pixel intensity threshold value including visceral adipose tissue (VAT) and subcutaneous adipose tissue content (SAT).
Results: Ten children underwent hepatic MRI only. Twenty-nine children underwent hepatic and adipose tissue distribution MRI. There was a correlation between hepatic fat fraction and VAT (r = 0.37, P < 0.05) but not body mass index or SAT. Elevated serum ALT was associated with a higher hepatic fat fraction (P < 0.001) and VAT (P = 0.06).
Conclusion: Visceral adiposity is a risk factor for pediatric NAFLD.
Similar articles
-
Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.Eur J Gastroenterol Hepatol. 2008 May;20(5):399-403. doi: 10.1097/MEG.0b013e3282f448af. Eur J Gastroenterol Hepatol. 2008. PMID: 18403941
-
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.Gut. 2009 Sep;58(9):1281-8. doi: 10.1136/gut.2008.151977. Epub 2008 Dec 11. Gut. 2009. PMID: 19074179
-
Regional differences in abdominal fat loss.Int J Obes (Lond). 2007 Jan;31(1):147-52. doi: 10.1038/sj.ijo.0803359. Epub 2006 Apr 25. Int J Obes (Lond). 2007. PMID: 16652124
-
[NASH in children].Nihon Rinsho. 2006 Jun;64(6):1168-72. Nihon Rinsho. 2006. PMID: 16768127 Review. Japanese.
-
Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21. doi: 10.1055/s-2002-38256. Horm Metab Res. 2002. PMID: 12660870 Review.
Cited by
-
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.Saudi J Gastroenterol. 2012 Jan-Feb;18(1):44-9. doi: 10.4103/1319-3767.91738. Saudi J Gastroenterol. 2012. PMID: 22249092 Free PMC article.
-
Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice.Biomed Res Int. 2016;2016:7867852. doi: 10.1155/2016/7867852. Epub 2016 Jan 31. Biomed Res Int. 2016. PMID: 26942201 Free PMC article.
-
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.Gastroenterology. 2008 May;134(5):1369-75. doi: 10.1053/j.gastro.2008.01.075. Epub 2008 Jan 30. Gastroenterology. 2008. PMID: 18355813 Free PMC article.
-
Overview of screening methods for fatty liver disease in children.World J Hepatol. 2012 Jan 27;4(1):1-4. doi: 10.4254/wjh.v4.i1.1. World J Hepatol. 2012. PMID: 22312449 Free PMC article.
-
Serum transaminases concentrations in obese children and adolescents.J Physiol Biochem. 2009 Mar;65(1):51-9. doi: 10.1007/BF03165969. J Physiol Biochem. 2009. PMID: 19588731
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials